Results for tag: "Equine Encephalitis Drug"

The Equine Encephalitis Drug market is a subset of the Animal Pharmaceuticals industry. It focuses on the development and sale of drugs used to treat equine encephalitis, a viral infection of the brain and spinal cord in horses. These drugs are typically administered in the form of injections, and may be used to treat both acute and chronic cases of the disease. The market is highly competitive, with a variety of companies offering different products. The Equine Encephalitis Drug market is driven by the need to treat horses suffering from the disease, as well as the increasing prevalence of the virus in certain regions. Additionally, the development of new drugs and treatments has helped to expand the market. Some companies in the Equine Encephalitis Drug market include Merck Animal Health, Boehringer Ingelheim Animal Health, Zoetis, and Elanco Animal Health. Show Less Read more